Risankizumab Effective Through 100 Weeks in Improving Signs, Symptoms of Psoriatic Arthritis
These data suggest risankizumab was both safe and efficacious through 100 weeks for PsA patients, with no new safety signals.
South Australia Monash University Department American College Of Rheumatology Monash University American College Active Psoriatic Arthritis
Source: hcplive.com